IRCT20110811007297N5招募中3 期
: A randomized, tripple blind, controlled, clinical trial effect of simple zofa (hyssopus officinalis) syrup on persistant asthma
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •older than 18 years old patients
- •confirm of disease by internist. diagnosis criteria: acording to NAEP EPR3 criteria for persistant asthma disease: FEV1: 60-80%
排除标准
- •history of allergy to plant of mint family
- •dissatisfaction of treatment in each stage
- •side effect development through treatment
- •theophylline cosumption
- •diabetic patients
- •convulsion history
- •pregnant patients
- •patienta that need to hospitalize
- •Exacerbation at beginning of study
- •diability in statement of symptom intensity
研究者
相似试验
已完成
3 期
OM-85 in the prevention of asthma in high-risk childreAsthmaRespiratory - AsthmaInflammatory and Immune System - Normal development and function of the immune systemACTRN12612000518864Child Health Research Centre, University of Queensland60
进行中（未招募）
不适用
A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab in combination with methotrexate (MTX) compared to MTX alone, in methotrexate-naïve patients with active rheumatoid arthritis.Rheumatoid arthritisEUCTR2005-002395-15-DEF. Hoffmann-La Roche Ltd.750
进行中（未招募）
不适用
A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab in combination with methotrexate (MTX) compared to MTX alone, in methotrexate-naïve patients with active rheumatoid arthritis.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2005-002395-15-SEF. Hoffmann-La Roche Ltd.750
进行中（未招募）
不适用
A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab in combination with methotrexate (MTX) compared to MTX alone, in methotrexate-naïve patients with active rheumatoid arthritis.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2005-002395-15-CZF. Hoffmann-La Roche Ltd.750
进行中（未招募）
不适用
A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab in combination with methotrexate (MTX) compared to MTX alone, in methotrexate-naïve patients with active rheumatoid arthritis.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2005-002395-15-BEF. Hoffmann-La Roche Ltd.750